 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
|||||||||
| Faculty Name and Research Interest | |
 |
Jan H. Beumer, PharmD, PhD |
 |
Kim C. Coley, PharmD, FCCP Factors that impact beneficial and adverse clinical outcomes to medications under conditions of usual care. |
 |
Kerry M. Empey, PharmD, PhD Our lab is interested in improving pulmonary infections in immunocompromised patients using immune modulating therapy. |
 |
Philip Empey, PharmD, PhD, BCPS |
 |
Tanya J. Fabian, PharmD, PhD Interaction between stress and mental and physical health; genetic vulnerability to depression; prevention strategies. |
 |
Thomas D. Nolin, PharmD, PhD Evaluation of the functional expression of drug metabolizing enzymes and transporters in humans, clinical PK/PD in patients with kidney disease, and the development of novel analytical techniques. |
 |
Samuel M. Poloyac, PharmD, PhD Role of cytochrome P450 enzymes in the pathogenesis of neurotraumatic disease. |
 |
Lisa C. Rohan, PhD Design and development of drug delivery systems for STI/HIV prevention and gynecologic oncology applications. |
 |
Raman Venkataramanan, PhD Drug disposition in transplant patients; regulation of drug metabolism; drug metabolism and transport during pregnancy. |
